Applications of 9-(4-Acetoxy-3-Acetoxymethylbutyl)-2-Amino-6-Chloropurine in Industrial Manufacturing

As a dedicated chemical manufacturer, we supply 9-(4-Acetoxy-3-Acetoxymethylbutyl)-2-Amino-6-Chloropurine to advanced industrial markets worldwide. The material supports high-value downstream applications in pharmaceutical intermediate synthesis, antiviral drug development, nucleoside analog API production, and specialty biochemical reagent manufacturing. Each scenario requires precise compliance, well-defined process integration, strict quality control, and reliable performance in customer formulation and production lines.

1. Intermediate for Antiviral Drug Synthesis

Pharmaceutical producers rely on this compound as a critical intermediate for synthesizing nucleoside-based antiviral drugs, especially in the manufacture of acyclovir analogs and related prodrugs. Its structure enables targeted modification during multi-step syntheses, supporting efficient development under regulated environments. Our facility's rigorous in-process QCs align with pharmaceutical industry requirements, serving scale-up and validation phases for leading drug manufacturers.

Industry compliance standards

• ICH Q7: Good Manufacturing Practice for Active Pharmaceutical Ingredients
• USP General Chapters — APIs and Intermediates
• EU GMP EudraLex Volume 4 Part II
• ISO 9001:2015 Quality Management

Typical usage ratio

• 5–15% molar equivalent as a core intermediate; adjusted per target API synthesis pathway and scale

Downstream process integration

• Introduced post-initial halogenation/purination, commonly in Step 2–4 of nucleoside assembly sequences
• Purification and crystallization performed prior to next functionalization

Final product types

• Acyclovir derivatives (bulk APIs)
• Valacyclovir intermediates
• Penciclovir prodrugs
• Nucleoside-based antiviral tablets and injectables

2. Precursor for Nucleoside Analog API Manufacturing

Leading active pharmaceutical ingredient manufacturers use this material as a building block for high-purity nucleoside analog APIs. Its tailored side chains and protected functional groups facilitate specific transformations, supporting patented routes required for patent-compliant generic API supply. By adhering closely to established synthetic control and impurity thresholds, our batches support direct transfer into validated API production lines.

Industry compliance standards

• ICH Q11: Development and Manufacture of Drug Substances
• US FDA CFR Title 21, Part 211 (Current Good Manufacturing Practice)
• Japanese Pharmacopoeia (JP) guidelines for nucleoside analogs
• Certificate of Suitability (CEP/EDQM) where required

Typical usage ratio

• 3–10% w/w in multi-gram to kilogram scale, calculated based on route efficiency and batch scale

Downstream process integration

• Charged into automated reactor systems, stepwise alongside solvents and catalysts
• Impurity profile monitored both in-line and by HPLC LC-MS analysis

Final product types

• High-purity nucleoside analog APIs (e.g., ganciclovir, famciclovir)
• API master batches for pharmaceutical tablet and capsule production
• Sterile injectable medicines

3. Key Intermediate in Custom Synthesis for Research Chemicals

Custom chemical synthesis providers and life science research groups utilize 9-(4-Acetoxy-3-Acetoxymethylbutyl)-2-Amino-6-Chloropurine as a customizable intermediate for developing novel purine analogs and biochemical probes. Its protected groups enable selective deprotection and conjugation strategies in both academic and industrial research. Batch documentation and analytical certificates facilitate smooth technology transfer to downstream R&D users.

Industry compliance standards

• ISO 9001:2015 (Analytical traceability and batch consistency)
• REACH registration (Europe) where >1 tpa
• SDS compliant to GHS/CLP requirements
• Custom project-specific analytical method validation

Typical usage ratio

• 0.1–5 mmol per reaction in R&D synthesis; up to 2% substrate basis in pilot production

Downstream process integration

• Dissolved in anhydrous conditions for regioselective functionalization
• Used as coupling partner for nucleoside modification under catalyzed conditions

Final product types

• Synthetic reference standards for analytical chemistry
• Custom nucleoside derivatives for bioassay development
• Research-scale compound libraries for pharmacological screening

4. Advanced Biochemical Reagent Manufacturing

Producers of advanced biochemical reagents for genomics, enzyme assays, and molecular diagnostics use this compound as a raw material for specialty nucleoside substrates. The defined acetoxy protection ensures selective reactivity and purity for sensitive enzymatic reactions. Each lot supports downstream manufacturing requiring batch-to-batch consistency and meets industrial documentation, safety, and traceability obligations.

Industry compliance standards

• ISO 13485:2016 (Quality Management Systems for Medical Devices)
• OECD Good Laboratory Practice (GLP) where applicable
• REACH Annex IV/V exemptions for reagents <10 kg/year/client
• In-house analytical protocols compliant with customer QC

Typical usage ratio

• 0.5–2% w/w in formulation of substrate mixes; ratio determined by assay sensitivity and enzyme substrate requirements

Downstream process integration

• Blended into substrate mixes via high-shear mixing
• Dispensed under nitrogen or argon atmosphere to preserve integrity

Final product types

• Specialty enzyme assay reagents for clinical laboratory use
• Nucleoside substrates for genotyping kits
• Molecular diagnostic test components
• Analytical control reagents for biopharma QC